| Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. MAP Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, Georgiou DM ... Nat Genet 25 (1), 17-19, 2000 | 560 | 2000 |
| Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease A Niemann, M Ruegg, V La Padula, A Schenone, U Suter The Journal of cell biology 170 (7), 1067-1078, 2005 | 480 | 2005 |
| The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings G Cavaletti, DR Cornblath, ISJ Merkies, TJ Postma, E Rossi, B Frigeni, ... Annals of Oncology 24 (2), 454-462, 2013 | 346 | 2013 |
| CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis V Fridman, B Bundy, MM Reilly, D Pareyson, C Bacon, J Burns, J Day, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (8), 873-878, 2015 | 337 | 2015 |
| Regional variation of Guillain-Barré syndrome AY Doets, C Verboon, B Van Den Berg, T Harbo, DR Cornblath, ... Brain 141 (10), 2866-2877, 2018 | 313 | 2018 |
| Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial D Pareyson, MM Reilly, A Schenone, GM Fabrizi, T Cavallaro, L Santoro, ... The Lancet Neurology 10 (4), 320-328, 2011 | 288 | 2011 |
| Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ... The Lancet Neurology 17 (1), 35-46, 2018 | 263 | 2018 |
| Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial E Nobile-Orazio, D Cocito, S Jann, A Uncini, E Beghi, P Messina, ... The Lancet Neurology 11 (6), 493-502, 2012 | 226 | 2012 |
| Sonography of the median nerve in Charcot-Marie-Tooth disease C Martinoli, A Schenone, S Bianchi, P Mandich, C Caponetto, ... American Journal of Roentgenology 178 (6), 1553-1556, 2002 | 187 | 2002 |
| Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin P Alberti, E Rossi, DR Cornblath, ISJ Merkies, TJ Postma, B Frigeni, ... Annals of oncology 25 (1), 257-264, 2014 | 177 | 2014 |
| Insulin‐like growth factor‐I prevents apoptosis in neurons after nerve growth factor withdrawal JW Russell, AJ Windebank, A Schenone, EL Feldman Journal of neurobiology 36 (4), 455-467, 1998 | 168 | 1998 |
| Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study G Cavaletti, A Beronio, L Reni, E Ghiglione, A Schenone, C Briani, G Zara, ... Neurology 62 (12), 2291-2293, 2004 | 162 | 2004 |
| Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database PE Doneddu, D Cocito, F Manganelli, R Fazio, C Briani, M Filosto, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (2), 125-132, 2019 | 146 | 2019 |
| Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside J Li, Y Bai, K Ghandour, P Qin, M Grandis, A Trostinskaia, E Ianakova, ... Brain 128 (5), 1168-1177, 2005 | 146 | 2005 |
| Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype A Cortese, R Lombardi, C Briani, I Callegari, L Benedetti, F Manganelli, ... Neurology: Neuroimmunology & Neuroinflammation 7 (1), e639, 2019 | 144 | 2019 |
| Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature L Benedetti, C Briani, D Franciotta, R Fazio, I Paolasso, C Comi, ... Journal of Neurology, Neurosurgery & Psychiatry 82 (3), 306-308, 2011 | 144 | 2011 |
| Peripheral nerves: a target for the action of neuroactive steroids RC Melcangi, ITR Cavarretta, M Ballabio, E Leonelli, A Schenone, ... Brain research reviews 48 (2), 328-338, 2005 | 140 | 2005 |
| International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in … BC Jacobs, B van den Berg, C Verboon, G Chavada, DR Cornblath, ... Journal of the Peripheral Nervous System 22 (2), 68-76, 2017 | 122 | 2017 |
| Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 L Maggi, L Bello, S Bonanno, A Govoni, C Caponnetto, L Passamano, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (11), 1166-1174, 2020 | 121 | 2020 |
| Predictors of response to rituximab in patients with neuropathy and anti–myelin associated glycoprotein immunoglobulin M L Benedetti, C Briani, M Grandis, T Vigo, M Gobbi, E Ghiglione, M Carpo, ... Journal of the Peripheral Nervous System 12 (2), 102-107, 2007 | 118 | 2007 |
